Senti Biosciences Holdings
SNTI
16 hedge funds and large institutions have $4.58M invested in Senti Biosciences Holdings in 2026 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 4 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
7% more funds holding
Funds holding: 15 → 16 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3.25% less ownership
Funds ownership: 21.35% → 18.11% (-3.2%)
22% less capital invested
Capital invested by funds: $5.84M → $4.58M (-$1.26M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$60.2K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$16.7K |
| 3 |
HF
HRT Financial
New York
|
+$14.4K |
| 4 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
+$11.6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3.97K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$46K |
| 2 |
Jane Street
New York
|
-$40K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.55K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$78 |
| 5 |
SS
SBI Securities
Tokyo,
Japan
|
-$2 |
SNTI Hedge Fund Activity: Q1 2026 in Review
16 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Senti Biosciences Holdings (SNTI) for Q1 2026, worth a combined $4.58M — down 22% from $5.84M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new SNTI positions and 4 closed out — a net gain of 3 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $60.2K. The largest seller was Virtu Financial, exiting entirely with an estimated $46K sold.
- 16 institutional investors held Senti Biosciences Holdings (SNTI) as of Q1 2026, up from 15 in Q4 2025.
- Funds reported $4.58M of Senti Biosciences Holdings stock for Q1 2026, down 22% quarter-over-quarter.
- 7 funds opened new Senti Biosciences Holdings positions in Q1 2026 and 4 closed out, a net change of +3 holders.
- The largest Senti Biosciences Holdings buyer in Q1 2026 was Geode Capital Management, an estimated $60.2K added.
- The largest Senti Biosciences Holdings seller in Q1 2026 was Virtu Financial, an estimated $46K sold.
Based on aggregated 13F filings for Q1 2026.